• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: April 11-15, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.


April 11-15, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products4/14/11Las Vegas, NVSeveral FDA StaffConference participantsNational Association of Tobacco Outlets 2011 Conference - Keynote Speaker
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Meghan Scott, Acting Associate Commissioner for External Affairs4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research4/11/11-4/15/11N/AN/AN/ANo Significant Meetings  
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/11/11-4/15/11N/AN/AN/ANo Significant Meetings  
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research4/13/11Berkeley, CAN/AN/APresentation at the Annual Spring Symposium of the Northern California Society of Toxicology Regional Chapter
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods4/11/11-4/15/11N/AN/AN/ANo Significant Meetings  
Ralph Tyler, J.D., Chief Counsel4/13/11Silver Spring, MDRick Blumberg, Jane Axelrad, Mike LevyJohn Manthei, Phil Perry (Latham & Watkins LLP); Gadi Weinreich (SNR Denton); Paul Rubin (Patton Boggs)KV Pharmaceutical
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs4/11/11-4/15/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/11/11Washington, DCVicki Seyfert-Margolis, Robert Temple, Darrell AbernathyM.F. Jarvis (Abbott Laboratories); Richard Hargreaves (Merck); Jeremy Berg (NIGMS, NIH)The American Society for Pharmacology and Experimental Therapeutics Scientific Program
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/14/11New York, NYN/ADavid Epstein (Novartis Pharmaceuticals); Joel Marcus (Alexandria Real Estate Equities); Donald Berry (The University of Texas)Alexandria Summit: Oncology 2011